257 related articles for article (PubMed ID: 28196704)
1. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.
Shibata A; Sugiura K; Furuta Y; Mukumoto Y; Kaminuma O; Akiyama M
J Autoimmun; 2017 Jun; 80():28-38. PubMed ID: 28196704
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature.
Okorie CL; Nayudu K; Nambudiri VE
Exp Dermatol; 2024 Jan; 33(1):e14934. PubMed ID: 37726967
[TBL] [Abstract][Full Text] [Related]
3. Novel use of Autoinflammatory Diseases Activity Index (AIDAI) captures skin and extracutaneous features to help manage pediatric DITRA: A case report and a proposal for a modified disease activity index in autoinflammatory keratinization disorders.
Stephenson C; Prajapati VH; Hunter C; Miettunen P
Pediatr Dermatol; 2020 Jul; 37(4):670-676. PubMed ID: 32301172
[TBL] [Abstract][Full Text] [Related]
4. [Autoinflammatory diseases in dermatology: DITRA and CAMPS].
Sugiura K
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):169-173. PubMed ID: 28747603
[TBL] [Abstract][Full Text] [Related]
5. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis.
Abbas O; Itani S; Ghosn S; Kibbi AG; Fidawi G; Farooq M; Shimomura Y; Kurban M
Dermatology; 2013; 226(1):28-31. PubMed ID: 23428889
[TBL] [Abstract][Full Text] [Related]
6. Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents.
Hospach T; Glowatzki F; Blankenburg F; Conzelmann D; Stirnkorb C; Müllerschön CS; von den Driesch P; Köhler LM; Rohlfs M; Klein C; Hauck F
Pediatr Rheumatol Online J; 2019 Jul; 17(1):37. PubMed ID: 31286990
[TBL] [Abstract][Full Text] [Related]
7. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
[TBL] [Abstract][Full Text] [Related]
8. TAK-242 ameliorates contact dermatitis exacerbated by IL-36 receptor antagonist deficiency.
Fukushima H; Iwata Y; Watanabe S; Saito K; Tanaka Y; Hasegawa Y; Akiyama M; Sugiura K
Sci Rep; 2020 Jan; 10(1):734. PubMed ID: 31959814
[TBL] [Abstract][Full Text] [Related]
9. IL36RN mutation causing generalized pustular psoriasis in a Palestinian patient.
Renert-Yuval Y; Horev L; Babay S; Tams S; Ramot Y; Zlotogorski A; Molho-Pessach V
Int J Dermatol; 2014 Jul; 53(7):866-8. PubMed ID: 24898045
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
Arakawa A; Ruzicka T; Prinz JC
JAMA Dermatol; 2016 Jul; 152(7):825-8. PubMed ID: 27096382
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte and monocyte apheresis can control juvenile generalized pustular psoriasis with mutation of IL36RN.
Koike Y; Okubo M; Kiyohara T; Fukuchi R; Sato Y; Kuwatsuka S; Takeichi T; Akiyama M; Sugiura K; Utani A
Br J Dermatol; 2017 Dec; 177(6):1732-1736. PubMed ID: 28369922
[TBL] [Abstract][Full Text] [Related]
12. First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra.
Rossi-Semerano L; Piram M; Chiaverini C; De Ricaud D; Smahi A; Koné-Paut I
Pediatrics; 2013 Oct; 132(4):e1043-7. PubMed ID: 24019411
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.
Ho PH; Tsai TF
J Dermatol; 2018 Nov; 45(11):1353-1356. PubMed ID: 30230584
[TBL] [Abstract][Full Text] [Related]
14. Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin.
Akiyama M; Takeichi T; McGrath JA; Sugiura K
J Dermatol Sci; 2018 May; 90(2):105-111. PubMed ID: 29422292
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene.
Mizukawa I; Kamata M; Shimizu T; Ito M; Watanabe A; Uchida H; Egawa S; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Sugiura K; Tada Y
J Dermatol; 2023 Dec; 50(12):1608-1613. PubMed ID: 37525499
[TBL] [Abstract][Full Text] [Related]
16. Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis.
Kanazawa N; Nakamura T; Mikita N; Furukawa F
J Dermatol; 2013 Sep; 40(9):749-51. PubMed ID: 23834760
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis.
Farooq M; Nakai H; Fujimoto A; Fujikawa H; Matsuyama A; Kariya N; Aizawa A; Fujiwara H; Ito M; Shimomura Y
Hum Mutat; 2013 Jan; 34(1):176-83. PubMed ID: 22903787
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of interleukin-36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan.
Hsieh CY; Huang YW; Huang YH; Tsai TF
Exp Dermatol; 2023 Aug; 32(8):1272-1278. PubMed ID: 36843341
[TBL] [Abstract][Full Text] [Related]
19. Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state.
Woller SA; Ravula SB; Tucci FC; Beaton G; Corr M; Isseroff RR; Soulika AM; Chigbrow M; Eddinger KA; Yaksh TL
Brain Behav Immun; 2016 Aug; 56():271-80. PubMed ID: 27044335
[TBL] [Abstract][Full Text] [Related]
20. Rapid response to secukinumab in a 5-year-old with deficiency of the interleukin-36 receptor antagonist (DITRA) with severe scalp and nail involvement.
Jing G; Bin W; Ying ZZ
Pediatr Dermatol; 2021 Sep; 38(5):1258-1263. PubMed ID: 34339530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
